Concentrated aqueous azalide formulations
AssigneeInsite Vision Incorporated
InventorsLyle Bowman, S. Kumar Chandrasekaran, Roy Duane Archibald, Stephen Pham, David Mufson
Life of this patent
Estimating the term…
Loading patent…
AssigneeInsite Vision Incorporated
InventorsLyle Bowman, S. Kumar Chandrasekaran, Roy Duane Archibald, Stephen Pham, David Mufson
Estimating the term…
The present invention relates to formulations of concentrated azalide antibiotics and methods for making and using them. Specifically, the invention relates to a method of treating an infection comprising administering to a patient in need thereof, an effective amount of a concentrated aqueous azalide antibiotic formulation made according to the method comprising dissolving an azalide antibiotic in an aqueous solution comprising a strong acid. The invention also relates to methods for making concentrated aqueous azalide antibiotic formulations for use in pulmonary infection, a nasopharyngeal infection, an otic infection, an ocular infection, a dermal or a vaginal infection. The invention also relates to concentrated aqueous azalide antibiotic formulations made by dissolving an azalide antibiotic in an aqueous solution comprising a strong acid.
A method of treating an infection comprising administering to a patient in need thereof, an effective amount of a concentrated aqueous azalide antibiotic formulation made according to the method comprising dissolving an azalide antibiotic in an aqueous solution comprising a strong acid.
The method of claim 16 wherein the anti-inflammatory agent is a dexamethasone.
A method of making a concentrated aqueous azalide antibiotic formulation comprising dissolving an azalide antibiotic in an aqueous solution comprising a strong acid.
A concentrated topical aqueous azalide antibiotic formulation made by the method comprising dissolving an azalide antibiotic in an aqueous solution comprising a strong acid.
Dependencies are inferred from the claim text.